LDN Social Media
Get connected with us on social networks
Low-dose Naltrexone for atopic dermatitis?
National Eczema Association
11 April 2019
https://nationaleczema.org/naltrexone/
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disorders, affecting up to 20 percent of children and 10 percent of adults. The main goals of treatment are to decrease itching and pain, dampen the skin inflammation, repair the skin barrier and restore healthy skin flora. Oral and topical naltrexone (at varying doses) have been shown to improve itch in patients with AD. LDN is certainly an emerging potential treatment that merits further study.